Literature DB >> 7908511

Splanchnic neural regulation of somatostatin secretion in the isolated perfused human pancreas.

F C Brunicardi1, D Elahi, D K Andersen.   

Abstract

OBJECTIVE: The somatostatin-secreting delta cells in the islets of Langerhans appear to be regulated by neural mechanisms that have not been defined clearly. In this study, the celiac neural bundle of the human pancreas was electrically stimulated in the presence and absence of selective neural antagonists. SUMMARY BACKGROUND DATA: The authors previously reported on studies of the splanchnic neural regulation of insulin, glucagon, and pancreatic polypeptide secretion. In these studies, alpha-adrenergic fibers appeared to have a predominant effect, strongly inhibiting the secretion of insulin, glucagon, and pancreatic polypeptide secretion. Cholinergic fibers appeared to stimulate strongly, although beta-adrenergic fibers weakly stimulated, the secretion of these hormones. Investigations of neural regulatory mechanisms governing human somatostatin release in vitro have not been previously reported.
METHODS: Pancreata were obtained from eight cadaveric organ donors. The isolated perfused human pancreas technique was used to assess the regulation of somatostatin secretion by the various neural fibers contained within the celiac plexus. The secretory response of somatostatin was examined in the presence of 16.7 mmol/L glucose, with and without neural stimulation, and specific neural antagonists.
RESULTS: The basal somatostatin secretion was 88 +/- 26 fmol/g/min and increased 131 +/- 23% (n = 8, p < 0.01) in response to 16.7 mmol/L glucose. The augmentation seen with glucose was inhibited 66 +/- 22% (n = 8, p < 0.05) during celiac neural bundle stimulation. Alpha-adrenergic blockade resulted in a 90 +/- 30% (n = 6, p < 0.01) augmentation of somatostatin release. Beta-adrenergic blockade caused a 13 +/- 2% (n = 6, p < 0.05) suppression of somatostatin release. Complete adrenergic blockade resulted in a 25 +/- 23% (n = 5, p = not significant) inhibition of somatostatin release. Cholinergic blockade resulted in a 40 +/- 10% (n = 6, p < 0.02) suppression of somatostatin release.
CONCLUSIONS: The predominant effect of celiac neural bundle stimulation was inhibition of somatostatin secretion through an alpha-adrenergic effect. Beta-adrenergic fibers stimulate somatostatin secretion; cholinergic fibers have a negligible effect on somatostatin secretion. These data suggest that the splanchnic innervation of the pancreas has a potent regulatory role in somatostatin release in this in vitro human model.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908511      PMCID: PMC1243133          DOI: 10.1097/00000658-199403000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

Review 1.  Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

2.  Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas.

Authors:  E Samols; G C Weir
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

3.  Pancreatic somatostatin secretion is suppressed by splanchnic nerve stimulation.

Authors:  M W Roy; M S Jones; R E Miller
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

4.  Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.

Authors:  T Wasada; R E Dobbs; V Harris; R H Unger
Journal:  Endocrinology       Date:  1981-04       Impact factor: 4.736

5.  Decreased release of somatostatin into the portal vein following electrical vagal stimulation in the cat.

Authors:  K Uvnäs-Wallensten; S Efendic; A Roovete; C Johansson
Journal:  Acta Physiol Scand       Date:  1980-08

6.  Effect of norepinephrine on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets.

Authors:  R L Sorenson; R P Elde; V Seybold
Journal:  Diabetes       Date:  1979-10       Impact factor: 9.461

7.  Radioimmunoassay of somatostatin and its application in the study of pancreatic somatostatin secretion in vitro.

Authors:  J Gerich; K Greene; M Hara; R Rizza; G Patton
Journal:  J Lab Clin Med       Date:  1979-06

8.  Effects of substance P and other peptides on the release of somatostatin, insulin, and glucagon in vitro.

Authors:  K Hermansen
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

9.  Acetylcholine stimulates insulin, glucagon, and somatostatin release in the perfused chicken pancreas.

Authors:  R N Honey; G C Weir
Journal:  Endocrinology       Date:  1980-10       Impact factor: 4.736

10.  Oxygen supply, oxygen consumption, and endocrine and exocrine secretions of the isolated, perfused, porcine pancreas.

Authors:  J J Holst; S L Jensen; O V Nielsen; T W Schwartz
Journal:  Acta Physiol Scand       Date:  1980-05
View more
  3 in total

1.  System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2009-01

Review 2.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

3.  Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.

Authors:  Leon S Farhy; Zhongmin Du; Qiang Zeng; Paula P Veldhuis; Michael L Johnson; Kenneth L Brayman; Anthony L McCall
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.